In order to better promote the improvement of the level of gynecology diagnosis and treatment in Dezhou City, a few days ago, the sixth Tianqu Science and Technology Forum in 2023 - Gynecology micro innovation Technology Clinical Application Forum was held, sponsored by Dezhou City Association of Science and Technology, sponsored by Dezhou Medical Association, Shandong University Qilu Hospital Dezhou Hospital.

This academic conference invited a number of well-known experts to give special lectures on gynecological minimally invasive surgery, standardized diagnosis and treatment of gynecological malignant tumors and other hot topics, and set up case discussion links to strengthen the academic exchanges of doctors, and the content is wonderful.

It is reported that the meeting specially invited Professor Yang Xingsheng, deputy director of the Women and Children Center of Shandong University Qilu Hospital, and other well-known experts to give special lectures on gynecological minimally invasive surgery, standardized diagnosis and treatment of gynecological malignant tumors, gynecological ultrasound diagnosis and treatment and other related hot topics.

Academic Lectures:

Tumor free improvement and paracentral treatment of LRH

Professor Zhu Lin, Executive Deputy Director and Director of the Gynecology Center of the Second Hospital of Shandong University, Director of the Department of Health of Gynecologic Endoscopy Level 4 surgery training base. Tumor-free operation and techniques during LRH surgery have always been a hot topic and difficult problem in gynecological tumor surgery. Professor Zhu Lin, as an expert in laparoscopy, has shared many years of clinical experience on how to improve tumor-free technology and paracentral treatment during LRH surgery. And through pictures, cases, videos and other ways vivid visual display, deepen everyone's impression.

   Interpretation of Chinese Menopause Management and Menopause hormone Therapy Guidelines (2023 edition)

   Professor Liu Ming, Deputy Director of Gynecology of Shandong Provincial Hospital, Director of gynecology of East Hospital, Deputy Director of Gynecology Minimally Invasive Branch of Shandong Provincial Doctor Association. At present, with the aging of society, long-term management of perimenopausal women is becoming more and more important. According to the latest edition of the Guidelines for Menopause Management and hormone therapy in China, Prof. Liu gave a detailed explanation from the aspects of menopause symptoms, patient evaluation, drug treatment principles and individualized plan formulation, adverse reactions and management.

    Interpretation of O-RADS ultrasonic classification management system

    Professor Tao Guowei, Executive Deputy Director of the Department of Ultrasound, Qilu Hospital, Shandong University, M.D., Master tutor. According to the O-RAS grading system, it explains in detail how to determine the grading according to the different manifestations of the patient's ovarian tumor under ultrasound images, how to judge and interpret the grading report results, and how to stratify management. And through the introduction of a number of rare diseases such as primary ovarian lymphoma, luteum during pregnancy and so on to deepen the understanding of theoretical knowledge. To assist clinicians in assessing the patient's condition and directing subsequent treatment.

    Guideline interpretation and patient management of POI

    Professor Wu Zhihong, postdoctoral fellow, Director of the Department of Gynecology, Shandong University Qilu Hospital. The meeting explained the definition and diagnosis of POI, the latest progress in diagnosis and treatment, long-term health problems of POI, bone metabolism problems, urogenital system problems, treatment principles, the comparison of classic and cutting-edge treatment methods, how to develop individual treatment plans, HRT treatment principles; Interpretation of POI guidelines for integrated Chinese and Western medicine treatment and the experience of Qilu Hospital; POI psychological intervention and genetic counseling; Long-term health and complication management.

    Application of ALA photodynamics in cervical LSIL

    Professor Jia Lin, M.D., Member of the CSCCP of China Eugenics Science Association. Professor Jalin detailed the current incidence of cervical cancer and the status quo of global diagnosis and treatment, the relationship with HPV infection, the change in the concept of cervical squamous intraepithelial lesions, the problems in diagnosis and treatment, Concept and outcome of LSIL, risk stratification management based on cervical cytology, treatment approach, ALA photodynamic therapy mechanism, treatment advantages, treatment process, treatment experience, management of adverse reactions.

    Treatment of early cervical cancer with fertility preservation function

    Professor Yang Xingsheng, Deputy Director, Professor and doctoral supervisor, Women and Children Center, Qilu Hospital, Shandong University. In the lecture, the epidemiological status of early cervical cancer, the selection of treatment, surgical indications and surgical methods, and the requirements of excision scope were elaborated. Current research status of indications, evolution of surgical methods, selection of surgical methods, quality control of surgical scope, prevention and management of intraoperative and postoperative complications, selection of postoperative adjuvant treatment, postoperative survival outcome, prognosis and fertility outcome.

    HPV infection and cervical cancer vaccine

    Professor Wang Huali, Chief physician of Qilu Hospital, Shandong University, Doctor of Medicine, Shandong University postgraduate tutor. Professor Wang Huali discussed the current situation of cervical cancer, the structure and characteristics of HPV virus, the relationship between HPV virus and the pathogenesis of cervical cancer, primary prevention of HPV infection, treatment of HPV persistent infection, points of attention and potential risks of local drug treatment, HPV vaccine selection and hot questions.

    To interpret the progress of diagnosis and treatment of endometrial cancer based on guidelines and consensus

    Professor Wang Changlin, Director of the Department of Gynecology of Traditional Chinese Medicine, Tai 'an Central Hospital, and tutor of master students of Shandong University of Traditional Chinese Medicine. Application of molecular typing of endometrial cancer, detection procedures, screening of Lynch syndrome, latest changes in endometrial cancer stage, treatment principles and experience for patients with advanced, recurrent, and unstaged endometrial cancer.

    Tumor-free operation of staging surgery for endometrial cancer by robotic laparoscopic surgery

    Professor Wang Xiaoyuan, chief physician, master tutor, Director of the Department of Gynecologic Oncology, the First Affiliated Hospital of Shandong First Medical University. Robotic laparoscopic tumor-free operation of endometrial cancer is a key operation for minimally invasive surgery to reduce postoperative recurrence. As an expert in robotic laparoscopic surgery, Director Wang Xiaoyuan This paper explained in detail the principle of no tumor during the operation, the common methods of operation, the precautions and skills, the advantages of Da Vinci surgical robot, and showed the wonderful surgical process of robot laparoscopic endometrial cancer with surgical video.

    Challenges and exploration of recurrent ovarian cancer

    Professor Li Peng, Chief physician of the Department of Obstetrics and Gynecology, Qilu Hospital, Shandong University, Deputy head of the Youth Group of Gynecologic Oncology Branch of Shandong Medical Association, Deputy head of the Chemotherapy and Clinical Research Group of Gynecologic Oncology Branch of Shandong Anticancer Association. Recurrence of ovarian cancer after treatment is a hot spot and difficulty in the diagnosis and treatment of gynecological tumors. China has the largest number of ovarian cancer patients with high malignancy and high recurrence rate. Professor Li Peng explained the classification of recurrent ovarian cancer, treatment strategies and experience of different types of recurrent ovarian cancer, current challenges, and the therapeutic application experience of PARP inhibitors, immunotherapy and antivascular drugs. The research results of RCT and its global application in recent years are reviewed systematically.

Lightning news reporter Zhao Shengnan correspondent Sun Xinru reports